Real-world Dosing Patterns of Rivaroxaban in the United States

Clinical trial NCT03242278 · COMPLETED

Trial details

NCT number: NCT03242278
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Atrial Fibrillation

Start date: 2016-02-12
Primary completion: 2016-03-01
Enrollment: 12507

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.